Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Acromegaly
Related studies linked through entity extraction aliases.
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
- Status
- TERMINATED
- Phase
- PHASE3
Inter-Assay Growth Hormone and IGF-I Variability
- Status
- WITHDRAWN
- Phase
- N/A
Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Prediction of Tumor Shrinkage in Acromegaly
- Status
- COMPLETED
- Phase
- N/A
Cardiovascular Outcome After Surgery or Somatostatin Analogues
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Acute Application of Pegvisomant and Octreotide in Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
- Status
- UNKNOWN
- Phase
- PHASE4
Ultrasound Guided Octreotide LAR Injection in Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4
Physiopathology of Sodium Retention in Acromegaly
- Status
- COMPLETED
- Phase
- NA
Preoperative Octreotide Treatment of Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)
- Status
- WITHDRAWN
- Phase
- PHASE2
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
- Status
- COMPLETED
- Phase
- N/A
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
- Status
- RECRUITING
- Phase
- N/A
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
- Status
- COMPLETED
- Phase
- PHASE4